Download Medical Notes on Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 Medical Notes

About This Presentation

Description:The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout has been predictable, certain events and trends have surprised. Check out the Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 for more details

Tags:Pharma, Biotech, Medtech Half-Year Review, 2020 , coronavirus, pandemic

Published on: Jul 30, 2020 | Views : 2674 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

Taming big Pharma

By: MattB
Views: 1977

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 2

By: MattB
Views: 1905

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.2

By: MattB
Views: 2806

FDA Role in Regulation of Cannabis Products

By: MattB
Views: 1785

Generics and Biosimilars Industry Response to COVID-19

By: MattB
Views: 1811

Indian API (Active Pharmaceutical Ingredient) Industry - Reaching The Full Potential

By: MattB
Views: 2210

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 2

By: MattB
Views: 1905

Coronavirus COVID-19 response for Pharma companies

By: KhushbuSG
Views: 1959

Barbiturates and Benzodiazepine

By: kvmegha
Views: 1724

India Pharma 2020 - Propelling access and acceptance realizing true potential

By: KhushbuSG
Views: 1879

MattB

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

HEALTH A TO Z